Vital Signs Monitoring Comprehensive Study by Type (Blood Pressure Monitors, Pulse Oximeters, Temperature Monitoring Devices, Other Vital Sign Monitors), Application (Hospitals and Clinics, Ambulatory Centers, Home Healthcare, Others), Distribution Chanel (Hospital Pharmacy, Retail Pharmacies, Online Websites, Others), Portability (Standalone, Portable) Players and Region - Global Market Outlook to 2027

Vital Signs Monitoring Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.9%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Vital sign monitoring is an assessment of heart rate, respiratory rate, blood pressure, oxygen saturation and body temperature. Vital signs are the baseline indicators of the patientís current health status. Vital signs are never stagnant because of the effect of a variety of internal and external factors such as many disease conditions, anxiety, pain, exercise etc. Increasing demand for portable devices, growing geriatric population and chronic disease are the key factors driving the growth of the vital signs monitoring market. According to AMA Research, the market for Vital Signs Monitoring is expected to register a CAGR of 7.9% during the forecast period to 2027. This growth is primarily driven by Rising Prevalence of Diseases .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitUnits
Value UnitUSD (Million)
Key Companies in StudyA&D Company (Japan), Contec Medical Systems (China), GE Healthcare (United States), Masimo Corporation (United States), Mindray Medical International Limited (China), Nihon Kohden (Japan), Omron Healthcare, Inc. (United States), Philips Healthcare (Netherlands), Spacelabs Healthcare, Inc. (United States) and SunTech Medical (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Equipment sector in the Asia Pacific region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as A&D Company (Japan), Contec Medical Systems (China), GE Healthcare (United States), Masimo Corporation (United States), Mindray Medical International Limited (China), Nihon Kohden (Japan), Omron Healthcare, Inc. (United States), Philips Healthcare (Netherlands), Spacelabs Healthcare, Inc. (United States) and SunTech Medical (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2022, Anelto Inc., one of the leading providers of remote patient monitoring (RPM) solutions, is integrating BioIntelliSense's FDA-approved BioSticker and BioButton wearable medical devices and data services with Anelto's RemoteCareLive, a continuous health monitoring and clinical intelligence company, BioIntelliSense, Inc. has partnered with . ! RPM platform., In 2022, Alder Hey Children's NHS Foundation Trust has partnered with digital health business Isansys Lifecare to improve home patient monitoring and reduce the burden on the healthcare system. and In 2021, California startup OnSky Health International is finding space in RPM with the introduction of the SkyPad system designed for continuous non-contact biosignal detection and emergency alert and paging systems. The system consists of sensor pads that use machine learning to detect vital signs, sleep quality, and body movements without touching your skin.
In 2022, India's private university, Amrita University, has announced the launch of a wearable health monitoring device for home use. Developed for wireless networks and applications, Amrita Spandanam is a wearable device that uses a finger clip to measure six body parameters: 6-lead ECG, blood oxygenation, blood pressure, respiration rate, heart rate and blood sugar. The company statement was developed with a patented AI algorithm that processes differential optical signals to provide critical body measurements "in less than a minute". and On 9th July 2018, Masimo released vital signs check application, an integrated patient data collection and workflow application for the Masimo Root patient monitoring and connectivity platform. Vital Signs Check, available for new and existing Root customers through a software upgrade, augments Rootís versatility by helping to automate hospital vital signs testing workflows.

Market Drivers
  • Rising Prevalence of Diseases
  • Growing Geriatric Population and Chronic Disease
  • Increasing Demand for Portable Devices

Market Trend
  • Technological Advancements in Devices

Restraints
  • High Cost of the Devices
  • Technical Issues Associated with the Devices

Opportunities
Increase in the Healthcare Expenditure in Emerging Economies, Growth in the Healthcare Industry Worldwide and Development of New Diagnostic Centre and Hospitals
Challenges
Lack of Awareness about Devices in Some Regions

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Vital Signs Monitoring Study Sheds Light on
— The Vital Signs Monitoring Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Vital Signs Monitoring industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Vital Signs Monitoring industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Blood Pressure Monitors
  • Pulse Oximeters
  • Temperature Monitoring Devices
  • Other Vital Sign Monitors
By Application
  • Hospitals and Clinics
  • Ambulatory Centers
  • Home Healthcare
  • Others
By Distribution Chanel
  • Hospital Pharmacy
  • Retail Pharmacies
  • Online Websites
  • Others

By Portability
  • Standalone
  • Portable

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Diseases
      • 3.2.2. Growing Geriatric Population and Chronic Disease
      • 3.2.3. Increasing Demand for Portable Devices
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Devices in Some Regions
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vital Signs Monitoring, by Type, Application, Distribution Chanel, Portability and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Vital Signs Monitoring (Value)
      • 5.2.1. Global Vital Signs Monitoring by: Type (Value)
        • 5.2.1.1. Blood Pressure Monitors
        • 5.2.1.2. Pulse Oximeters
        • 5.2.1.3. Temperature Monitoring Devices
        • 5.2.1.4. Other Vital Sign Monitors
      • 5.2.2. Global Vital Signs Monitoring by: Application (Value)
        • 5.2.2.1. Hospitals and Clinics
        • 5.2.2.2. Ambulatory Centers
        • 5.2.2.3. Home Healthcare
        • 5.2.2.4. Others
      • 5.2.3. Global Vital Signs Monitoring by: Distribution Chanel (Value)
        • 5.2.3.1. Hospital Pharmacy
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Websites
        • 5.2.3.4. Others
      • 5.2.4. Global Vital Signs Monitoring by: Portability (Value)
        • 5.2.4.1. Standalone
        • 5.2.4.2. Portable
      • 5.2.5. Global Vital Signs Monitoring Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Vital Signs Monitoring (Volume)
      • 5.3.1. Global Vital Signs Monitoring by: Type (Volume)
        • 5.3.1.1. Blood Pressure Monitors
        • 5.3.1.2. Pulse Oximeters
        • 5.3.1.3. Temperature Monitoring Devices
        • 5.3.1.4. Other Vital Sign Monitors
      • 5.3.2. Global Vital Signs Monitoring by: Application (Volume)
        • 5.3.2.1. Hospitals and Clinics
        • 5.3.2.2. Ambulatory Centers
        • 5.3.2.3. Home Healthcare
        • 5.3.2.4. Others
      • 5.3.3. Global Vital Signs Monitoring by: Distribution Chanel (Volume)
        • 5.3.3.1. Hospital Pharmacy
        • 5.3.3.2. Retail Pharmacies
        • 5.3.3.3. Online Websites
        • 5.3.3.4. Others
      • 5.3.4. Global Vital Signs Monitoring by: Portability (Volume)
        • 5.3.4.1. Standalone
        • 5.3.4.2. Portable
      • 5.3.5. Global Vital Signs Monitoring Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Vital Signs Monitoring (Price)
      • 5.4.1. Global Vital Signs Monitoring by: Type (Price)
  • 6. Vital Signs Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. A&D Company (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Contec Medical Systems (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Masimo Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mindray Medical International Limited (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nihon Kohden (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Omron Healthcare, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Philips Healthcare (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Spacelabs Healthcare, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SunTech Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Vital Signs Monitoring Sale, by Type, Application, Distribution Chanel, Portability and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Vital Signs Monitoring (Value)
      • 7.2.1. Global Vital Signs Monitoring by: Type (Value)
        • 7.2.1.1. Blood Pressure Monitors
        • 7.2.1.2. Pulse Oximeters
        • 7.2.1.3. Temperature Monitoring Devices
        • 7.2.1.4. Other Vital Sign Monitors
      • 7.2.2. Global Vital Signs Monitoring by: Application (Value)
        • 7.2.2.1. Hospitals and Clinics
        • 7.2.2.2. Ambulatory Centers
        • 7.2.2.3. Home Healthcare
        • 7.2.2.4. Others
      • 7.2.3. Global Vital Signs Monitoring by: Distribution Chanel (Value)
        • 7.2.3.1. Hospital Pharmacy
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Websites
        • 7.2.3.4. Others
      • 7.2.4. Global Vital Signs Monitoring by: Portability (Value)
        • 7.2.4.1. Standalone
        • 7.2.4.2. Portable
      • 7.2.5. Global Vital Signs Monitoring Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Vital Signs Monitoring (Volume)
      • 7.3.1. Global Vital Signs Monitoring by: Type (Volume)
        • 7.3.1.1. Blood Pressure Monitors
        • 7.3.1.2. Pulse Oximeters
        • 7.3.1.3. Temperature Monitoring Devices
        • 7.3.1.4. Other Vital Sign Monitors
      • 7.3.2. Global Vital Signs Monitoring by: Application (Volume)
        • 7.3.2.1. Hospitals and Clinics
        • 7.3.2.2. Ambulatory Centers
        • 7.3.2.3. Home Healthcare
        • 7.3.2.4. Others
      • 7.3.3. Global Vital Signs Monitoring by: Distribution Chanel (Volume)
        • 7.3.3.1. Hospital Pharmacy
        • 7.3.3.2. Retail Pharmacies
        • 7.3.3.3. Online Websites
        • 7.3.3.4. Others
      • 7.3.4. Global Vital Signs Monitoring by: Portability (Volume)
        • 7.3.4.1. Standalone
        • 7.3.4.2. Portable
      • 7.3.5. Global Vital Signs Monitoring Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Vital Signs Monitoring (Price)
      • 7.4.1. Global Vital Signs Monitoring by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vital Signs Monitoring: by Type(USD Million)
  • Table 2. Vital Signs Monitoring Blood Pressure Monitors , by Region USD Million (2016-2021)
  • Table 3. Vital Signs Monitoring Pulse Oximeters , by Region USD Million (2016-2021)
  • Table 4. Vital Signs Monitoring Temperature Monitoring Devices , by Region USD Million (2016-2021)
  • Table 5. Vital Signs Monitoring Other Vital Sign Monitors , by Region USD Million (2016-2021)
  • Table 6. Vital Signs Monitoring: by Application(USD Million)
  • Table 7. Vital Signs Monitoring Hospitals and Clinics , by Region USD Million (2016-2021)
  • Table 8. Vital Signs Monitoring Ambulatory Centers , by Region USD Million (2016-2021)
  • Table 9. Vital Signs Monitoring Home Healthcare , by Region USD Million (2016-2021)
  • Table 10. Vital Signs Monitoring Others , by Region USD Million (2016-2021)
  • Table 11. Vital Signs Monitoring: by Distribution Chanel(USD Million)
  • Table 12. Vital Signs Monitoring Hospital Pharmacy , by Region USD Million (2016-2021)
  • Table 13. Vital Signs Monitoring Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 14. Vital Signs Monitoring Online Websites , by Region USD Million (2016-2021)
  • Table 15. Vital Signs Monitoring Others , by Region USD Million (2016-2021)
  • Table 16. Vital Signs Monitoring: by Portability(USD Million)
  • Table 17. Vital Signs Monitoring Standalone , by Region USD Million (2016-2021)
  • Table 18. Vital Signs Monitoring Portable , by Region USD Million (2016-2021)
  • Table 19. South America Vital Signs Monitoring, by Country USD Million (2016-2021)
  • Table 20. South America Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 21. South America Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 22. South America Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 23. South America Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 24. Brazil Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 25. Brazil Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 26. Brazil Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 27. Brazil Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 28. Argentina Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 29. Argentina Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 30. Argentina Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 31. Argentina Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 32. Rest of South America Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 33. Rest of South America Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 34. Rest of South America Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 35. Rest of South America Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 36. Asia Pacific Vital Signs Monitoring, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 38. Asia Pacific Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 39. Asia Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 40. Asia Pacific Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 41. China Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 42. China Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 43. China Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 44. China Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 45. Japan Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 46. Japan Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 47. Japan Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 48. Japan Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 49. India Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 50. India Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 51. India Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 52. India Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 53. South Korea Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 54. South Korea Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 55. South Korea Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 56. South Korea Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 57. Taiwan Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 58. Taiwan Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 59. Taiwan Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 60. Taiwan Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 61. Australia Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 62. Australia Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 63. Australia Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 64. Australia Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 69. Europe Vital Signs Monitoring, by Country USD Million (2016-2021)
  • Table 70. Europe Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 71. Europe Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 72. Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 73. Europe Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 74. Germany Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 75. Germany Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 76. Germany Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 77. Germany Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 78. France Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 79. France Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 80. France Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 81. France Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 82. Italy Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 83. Italy Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 84. Italy Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 85. Italy Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 86. United Kingdom Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 87. United Kingdom Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 88. United Kingdom Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 89. United Kingdom Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 90. Netherlands Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 91. Netherlands Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 92. Netherlands Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 93. Netherlands Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 94. Rest of Europe Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 95. Rest of Europe Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 96. Rest of Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 97. Rest of Europe Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 98. MEA Vital Signs Monitoring, by Country USD Million (2016-2021)
  • Table 99. MEA Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 100. MEA Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 101. MEA Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 102. MEA Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 103. Middle East Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 104. Middle East Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 105. Middle East Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 106. Middle East Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 107. Africa Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 108. Africa Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 109. Africa Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 110. Africa Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 111. North America Vital Signs Monitoring, by Country USD Million (2016-2021)
  • Table 112. North America Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 113. North America Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 114. North America Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 115. North America Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 116. United States Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 117. United States Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 118. United States Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 119. United States Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 120. Canada Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 121. Canada Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 122. Canada Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 123. Canada Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 124. Mexico Vital Signs Monitoring, by Type USD Million (2016-2021)
  • Table 125. Mexico Vital Signs Monitoring, by Application USD Million (2016-2021)
  • Table 126. Mexico Vital Signs Monitoring, by Distribution Chanel USD Million (2016-2021)
  • Table 127. Mexico Vital Signs Monitoring, by Portability USD Million (2016-2021)
  • Table 128. Vital Signs Monitoring Sales: by Type(Units)
  • Table 129. Vital Signs Monitoring Sales Blood Pressure Monitors , by Region Units (2016-2021)
  • Table 130. Vital Signs Monitoring Sales Pulse Oximeters , by Region Units (2016-2021)
  • Table 131. Vital Signs Monitoring Sales Temperature Monitoring Devices , by Region Units (2016-2021)
  • Table 132. Vital Signs Monitoring Sales Other Vital Sign Monitors , by Region Units (2016-2021)
  • Table 133. Vital Signs Monitoring Sales: by Application(Units)
  • Table 134. Vital Signs Monitoring Sales Hospitals and Clinics , by Region Units (2016-2021)
  • Table 135. Vital Signs Monitoring Sales Ambulatory Centers , by Region Units (2016-2021)
  • Table 136. Vital Signs Monitoring Sales Home Healthcare , by Region Units (2016-2021)
  • Table 137. Vital Signs Monitoring Sales Others , by Region Units (2016-2021)
  • Table 138. Vital Signs Monitoring Sales: by Distribution Chanel(Units)
  • Table 139. Vital Signs Monitoring Sales Hospital Pharmacy , by Region Units (2016-2021)
  • Table 140. Vital Signs Monitoring Sales Retail Pharmacies , by Region Units (2016-2021)
  • Table 141. Vital Signs Monitoring Sales Online Websites , by Region Units (2016-2021)
  • Table 142. Vital Signs Monitoring Sales Others , by Region Units (2016-2021)
  • Table 143. Vital Signs Monitoring Sales: by Portability(Units)
  • Table 144. Vital Signs Monitoring Sales Standalone , by Region Units (2016-2021)
  • Table 145. Vital Signs Monitoring Sales Portable , by Region Units (2016-2021)
  • Table 146. South America Vital Signs Monitoring Sales, by Country Units (2016-2021)
  • Table 147. South America Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 148. South America Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 149. South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 150. South America Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 151. Brazil Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 152. Brazil Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 153. Brazil Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 154. Brazil Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 155. Argentina Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 156. Argentina Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 157. Argentina Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 158. Argentina Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 159. Rest of South America Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 160. Rest of South America Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 161. Rest of South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 162. Rest of South America Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 163. Asia Pacific Vital Signs Monitoring Sales, by Country Units (2016-2021)
  • Table 164. Asia Pacific Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 165. Asia Pacific Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 166. Asia Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 167. Asia Pacific Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 168. China Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 169. China Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 170. China Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 171. China Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 172. Japan Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 173. Japan Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 174. Japan Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 175. Japan Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 176. India Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 177. India Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 178. India Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 179. India Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 180. South Korea Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 181. South Korea Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 182. South Korea Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 183. South Korea Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 184. Taiwan Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 185. Taiwan Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 186. Taiwan Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 187. Taiwan Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 188. Australia Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 189. Australia Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 190. Australia Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 191. Australia Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 192. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 193. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 194. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 195. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 196. Europe Vital Signs Monitoring Sales, by Country Units (2016-2021)
  • Table 197. Europe Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 198. Europe Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 199. Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 200. Europe Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 201. Germany Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 202. Germany Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 203. Germany Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 204. Germany Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 205. France Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 206. France Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 207. France Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 208. France Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 209. Italy Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 210. Italy Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 211. Italy Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 212. Italy Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 213. United Kingdom Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 214. United Kingdom Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 215. United Kingdom Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 216. United Kingdom Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 217. Netherlands Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 218. Netherlands Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 219. Netherlands Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 220. Netherlands Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 221. Rest of Europe Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 222. Rest of Europe Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 223. Rest of Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 224. Rest of Europe Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 225. MEA Vital Signs Monitoring Sales, by Country Units (2016-2021)
  • Table 226. MEA Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 227. MEA Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 228. MEA Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 229. MEA Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 230. Middle East Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 231. Middle East Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 232. Middle East Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 233. Middle East Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 234. Africa Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 235. Africa Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 236. Africa Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 237. Africa Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 238. North America Vital Signs Monitoring Sales, by Country Units (2016-2021)
  • Table 239. North America Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 240. North America Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 241. North America Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 242. North America Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 243. United States Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 244. United States Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 245. United States Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 246. United States Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 247. Canada Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 248. Canada Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 249. Canada Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 250. Canada Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 251. Mexico Vital Signs Monitoring Sales, by Type Units (2016-2021)
  • Table 252. Mexico Vital Signs Monitoring Sales, by Application Units (2016-2021)
  • Table 253. Mexico Vital Signs Monitoring Sales, by Distribution Chanel Units (2016-2021)
  • Table 254. Mexico Vital Signs Monitoring Sales, by Portability Units (2016-2021)
  • Table 255. Vital Signs Monitoring: by Type(USD/Units)
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Vital Signs Monitoring: by Type(USD Million)
  • Table 267. Vital Signs Monitoring Blood Pressure Monitors , by Region USD Million (2022-2027)
  • Table 268. Vital Signs Monitoring Pulse Oximeters , by Region USD Million (2022-2027)
  • Table 269. Vital Signs Monitoring Temperature Monitoring Devices , by Region USD Million (2022-2027)
  • Table 270. Vital Signs Monitoring Other Vital Sign Monitors , by Region USD Million (2022-2027)
  • Table 271. Vital Signs Monitoring: by Application(USD Million)
  • Table 272. Vital Signs Monitoring Hospitals and Clinics , by Region USD Million (2022-2027)
  • Table 273. Vital Signs Monitoring Ambulatory Centers , by Region USD Million (2022-2027)
  • Table 274. Vital Signs Monitoring Home Healthcare , by Region USD Million (2022-2027)
  • Table 275. Vital Signs Monitoring Others , by Region USD Million (2022-2027)
  • Table 276. Vital Signs Monitoring: by Distribution Chanel(USD Million)
  • Table 277. Vital Signs Monitoring Hospital Pharmacy , by Region USD Million (2022-2027)
  • Table 278. Vital Signs Monitoring Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 279. Vital Signs Monitoring Online Websites , by Region USD Million (2022-2027)
  • Table 280. Vital Signs Monitoring Others , by Region USD Million (2022-2027)
  • Table 281. Vital Signs Monitoring: by Portability(USD Million)
  • Table 282. Vital Signs Monitoring Standalone , by Region USD Million (2022-2027)
  • Table 283. Vital Signs Monitoring Portable , by Region USD Million (2022-2027)
  • Table 284. South America Vital Signs Monitoring, by Country USD Million (2022-2027)
  • Table 285. South America Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 286. South America Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 287. South America Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 288. South America Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 289. Brazil Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 290. Brazil Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 291. Brazil Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 292. Brazil Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 293. Argentina Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 294. Argentina Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 295. Argentina Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 296. Argentina Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 297. Rest of South America Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 298. Rest of South America Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 299. Rest of South America Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 300. Rest of South America Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 301. Asia Pacific Vital Signs Monitoring, by Country USD Million (2022-2027)
  • Table 302. Asia Pacific Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 303. Asia Pacific Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 304. Asia Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 305. Asia Pacific Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 306. China Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 307. China Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 308. China Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 309. China Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 310. Japan Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 311. Japan Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 312. Japan Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 313. Japan Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 314. India Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 315. India Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 316. India Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 317. India Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 318. South Korea Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 319. South Korea Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 320. South Korea Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 321. South Korea Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 322. Taiwan Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 323. Taiwan Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 324. Taiwan Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 325. Taiwan Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 326. Australia Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 327. Australia Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 328. Australia Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 329. Australia Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 330. Rest of Asia-Pacific Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 331. Rest of Asia-Pacific Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 332. Rest of Asia-Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 333. Rest of Asia-Pacific Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 334. Europe Vital Signs Monitoring, by Country USD Million (2022-2027)
  • Table 335. Europe Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 336. Europe Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 337. Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 338. Europe Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 339. Germany Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 340. Germany Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 341. Germany Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 342. Germany Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 343. France Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 344. France Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 345. France Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 346. France Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 347. Italy Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 348. Italy Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 349. Italy Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 350. Italy Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 351. United Kingdom Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 352. United Kingdom Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 353. United Kingdom Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 354. United Kingdom Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 355. Netherlands Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 356. Netherlands Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 357. Netherlands Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 358. Netherlands Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 359. Rest of Europe Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 360. Rest of Europe Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 361. Rest of Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 362. Rest of Europe Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 363. MEA Vital Signs Monitoring, by Country USD Million (2022-2027)
  • Table 364. MEA Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 365. MEA Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 366. MEA Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 367. MEA Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 368. Middle East Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 369. Middle East Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 370. Middle East Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 371. Middle East Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 372. Africa Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 373. Africa Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 374. Africa Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 375. Africa Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 376. North America Vital Signs Monitoring, by Country USD Million (2022-2027)
  • Table 377. North America Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 378. North America Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 379. North America Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 380. North America Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 381. United States Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 382. United States Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 383. United States Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 384. United States Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 385. Canada Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 386. Canada Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 387. Canada Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 388. Canada Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 389. Mexico Vital Signs Monitoring, by Type USD Million (2022-2027)
  • Table 390. Mexico Vital Signs Monitoring, by Application USD Million (2022-2027)
  • Table 391. Mexico Vital Signs Monitoring, by Distribution Chanel USD Million (2022-2027)
  • Table 392. Mexico Vital Signs Monitoring, by Portability USD Million (2022-2027)
  • Table 393. Vital Signs Monitoring Sales: by Type(Units)
  • Table 394. Vital Signs Monitoring Sales Blood Pressure Monitors , by Region Units (2022-2027)
  • Table 395. Vital Signs Monitoring Sales Pulse Oximeters , by Region Units (2022-2027)
  • Table 396. Vital Signs Monitoring Sales Temperature Monitoring Devices , by Region Units (2022-2027)
  • Table 397. Vital Signs Monitoring Sales Other Vital Sign Monitors , by Region Units (2022-2027)
  • Table 398. Vital Signs Monitoring Sales: by Application(Units)
  • Table 399. Vital Signs Monitoring Sales Hospitals and Clinics , by Region Units (2022-2027)
  • Table 400. Vital Signs Monitoring Sales Ambulatory Centers , by Region Units (2022-2027)
  • Table 401. Vital Signs Monitoring Sales Home Healthcare , by Region Units (2022-2027)
  • Table 402. Vital Signs Monitoring Sales Others , by Region Units (2022-2027)
  • Table 403. Vital Signs Monitoring Sales: by Distribution Chanel(Units)
  • Table 404. Vital Signs Monitoring Sales Hospital Pharmacy , by Region Units (2022-2027)
  • Table 405. Vital Signs Monitoring Sales Retail Pharmacies , by Region Units (2022-2027)
  • Table 406. Vital Signs Monitoring Sales Online Websites , by Region Units (2022-2027)
  • Table 407. Vital Signs Monitoring Sales Others , by Region Units (2022-2027)
  • Table 408. Vital Signs Monitoring Sales: by Portability(Units)
  • Table 409. Vital Signs Monitoring Sales Standalone , by Region Units (2022-2027)
  • Table 410. Vital Signs Monitoring Sales Portable , by Region Units (2022-2027)
  • Table 411. South America Vital Signs Monitoring Sales, by Country Units (2022-2027)
  • Table 412. South America Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 413. South America Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 414. South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 415. South America Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 416. Brazil Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 417. Brazil Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 418. Brazil Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 419. Brazil Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 420. Argentina Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 421. Argentina Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 422. Argentina Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 423. Argentina Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 424. Rest of South America Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 425. Rest of South America Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 426. Rest of South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 427. Rest of South America Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 428. Asia Pacific Vital Signs Monitoring Sales, by Country Units (2022-2027)
  • Table 429. Asia Pacific Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 430. Asia Pacific Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 431. Asia Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 432. Asia Pacific Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 433. China Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 434. China Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 435. China Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 436. China Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 437. Japan Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 438. Japan Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 439. Japan Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 440. Japan Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 441. India Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 442. India Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 443. India Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 444. India Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 445. South Korea Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 446. South Korea Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 447. South Korea Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 448. South Korea Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 449. Taiwan Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 450. Taiwan Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 451. Taiwan Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 452. Taiwan Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 453. Australia Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 454. Australia Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 455. Australia Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 456. Australia Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 457. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 458. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 459. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 460. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 461. Europe Vital Signs Monitoring Sales, by Country Units (2022-2027)
  • Table 462. Europe Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 463. Europe Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 464. Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 465. Europe Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 466. Germany Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 467. Germany Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 468. Germany Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 469. Germany Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 470. France Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 471. France Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 472. France Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 473. France Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 474. Italy Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 475. Italy Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 476. Italy Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 477. Italy Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 478. United Kingdom Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 479. United Kingdom Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 480. United Kingdom Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 481. United Kingdom Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 482. Netherlands Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 483. Netherlands Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 484. Netherlands Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 485. Netherlands Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 486. Rest of Europe Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 487. Rest of Europe Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 488. Rest of Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 489. Rest of Europe Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 490. MEA Vital Signs Monitoring Sales, by Country Units (2022-2027)
  • Table 491. MEA Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 492. MEA Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 493. MEA Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 494. MEA Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 495. Middle East Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 496. Middle East Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 497. Middle East Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 498. Middle East Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 499. Africa Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 500. Africa Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 501. Africa Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 502. Africa Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 503. North America Vital Signs Monitoring Sales, by Country Units (2022-2027)
  • Table 504. North America Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 505. North America Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 506. North America Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 507. North America Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 508. United States Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 509. United States Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 510. United States Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 511. United States Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 512. Canada Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 513. Canada Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 514. Canada Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 515. Canada Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 516. Mexico Vital Signs Monitoring Sales, by Type Units (2022-2027)
  • Table 517. Mexico Vital Signs Monitoring Sales, by Application Units (2022-2027)
  • Table 518. Mexico Vital Signs Monitoring Sales, by Distribution Chanel Units (2022-2027)
  • Table 519. Mexico Vital Signs Monitoring Sales, by Portability Units (2022-2027)
  • Table 520. Vital Signs Monitoring: by Type(USD/Units)
  • Table 521. Research Programs/Design for This Report
  • Table 522. Key Data Information from Secondary Sources
  • Table 523. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vital Signs Monitoring: by Type USD Million (2016-2021)
  • Figure 5. Global Vital Signs Monitoring: by Application USD Million (2016-2021)
  • Figure 6. Global Vital Signs Monitoring: by Distribution Chanel USD Million (2016-2021)
  • Figure 7. Global Vital Signs Monitoring: by Portability USD Million (2016-2021)
  • Figure 8. South America Vital Signs Monitoring Share (%), by Country
  • Figure 9. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 10. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 11. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 12. North America Vital Signs Monitoring Share (%), by Country
  • Figure 13. Global Vital Signs Monitoring: by Type Units (2016-2021)
  • Figure 14. Global Vital Signs Monitoring: by Application Units (2016-2021)
  • Figure 15. Global Vital Signs Monitoring: by Distribution Chanel Units (2016-2021)
  • Figure 16. Global Vital Signs Monitoring: by Portability Units (2016-2021)
  • Figure 17. South America Vital Signs Monitoring Share (%), by Country
  • Figure 18. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 19. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 20. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 21. North America Vital Signs Monitoring Share (%), by Country
  • Figure 22. Global Vital Signs Monitoring: by Type USD/Units (2016-2021)
  • Figure 23. Global Vital Signs Monitoring share by Players 2021 (%)
  • Figure 24. Global Vital Signs Monitoring share by Players (Top 3) 2021(%)
  • Figure 25. Global Vital Signs Monitoring share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. A&D Company (Japan) Revenue, Net Income and Gross profit
  • Figure 28. A&D Company (Japan) Revenue: by Geography 2021
  • Figure 29. Contec Medical Systems (China) Revenue, Net Income and Gross profit
  • Figure 30. Contec Medical Systems (China) Revenue: by Geography 2021
  • Figure 31. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 32. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 33. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Masimo Corporation (United States) Revenue: by Geography 2021
  • Figure 35. Mindray Medical International Limited (China) Revenue, Net Income and Gross profit
  • Figure 36. Mindray Medical International Limited (China) Revenue: by Geography 2021
  • Figure 37. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Nihon Kohden (Japan) Revenue: by Geography 2021
  • Figure 39. Omron Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Omron Healthcare, Inc. (United States) Revenue: by Geography 2021
  • Figure 41. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 42. Philips Healthcare (Netherlands) Revenue: by Geography 2021
  • Figure 43. Spacelabs Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Spacelabs Healthcare, Inc. (United States) Revenue: by Geography 2021
  • Figure 45. SunTech Medical (United States) Revenue, Net Income and Gross profit
  • Figure 46. SunTech Medical (United States) Revenue: by Geography 2021
  • Figure 47. Global Vital Signs Monitoring: by Type USD Million (2022-2027)
  • Figure 48. Global Vital Signs Monitoring: by Application USD Million (2022-2027)
  • Figure 49. Global Vital Signs Monitoring: by Distribution Chanel USD Million (2022-2027)
  • Figure 50. Global Vital Signs Monitoring: by Portability USD Million (2022-2027)
  • Figure 51. South America Vital Signs Monitoring Share (%), by Country
  • Figure 52. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 53. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 54. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 55. North America Vital Signs Monitoring Share (%), by Country
  • Figure 56. Global Vital Signs Monitoring: by Type Units (2022-2027)
  • Figure 57. Global Vital Signs Monitoring: by Application Units (2022-2027)
  • Figure 58. Global Vital Signs Monitoring: by Distribution Chanel Units (2022-2027)
  • Figure 59. Global Vital Signs Monitoring: by Portability Units (2022-2027)
  • Figure 60. South America Vital Signs Monitoring Share (%), by Country
  • Figure 61. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 62. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 63. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 64. North America Vital Signs Monitoring Share (%), by Country
  • Figure 65. Global Vital Signs Monitoring: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • A&D Company (Japan)
  • Contec Medical Systems (China)
  • GE Healthcare (United States)
  • Masimo Corporation (United States)
  • Mindray Medical International Limited (China)
  • Nihon Kohden (Japan)
  • Omron Healthcare, Inc. (United States)
  • Philips Healthcare (Netherlands)
  • Spacelabs Healthcare, Inc. (United States)
  • SunTech Medical (United States)
Additional players considered in the study are as follows:
Welch Allyn, Inc. (United States) , Boston Scientific (United States) , Natus Medical Incorporated (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 158 Pages 69 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Vital Signs Monitoring Market are A&D Company (Japan), Contec Medical Systems (China), GE Healthcare (United States), Masimo Corporation (United States), Mindray Medical International Limited (China), Nihon Kohden (Japan), Omron Healthcare, Inc. (United States), Philips Healthcare (Netherlands), Spacelabs Healthcare, Inc. (United States) and SunTech Medical (United States) etc.
Hospitals and Clinics segment in Global market to hold robust market share owing to "Rising Prevalence of Diseases ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Vital Signs Monitoring market throughout the forecasted period.

Know More About Global Vital Signs Monitoring Market Report?